Eric Meizlish has 20+ years of experience as an entrepreneur, operator, and investor in technology-enabled businesses.

Currently, he is the CEO of Prendio-BioProcure, a PE-backed company that offers procurement software and services to biotech and life science companies to drive cost savings and accelerate R&D.

Previously, he was a co-founder of Lumere and served as its President and Chief Strategy Officer until its acquisition by GHX. Lumere was the leading provider of evidence and data-driven solutions that reduce care variation and support successful clinical cost management. After the acquisition, Eric served as the Senior Vice President of Strategy and Corporate Development at GHX and was a member of the global leadership team.

He also spent the first several years of his career at Citadel, where he invested in publicly traded Technology, Media, and Telecommunications companies.

Eric is a board member and advisor for several growth-stage healthcare technology businesses and serves on the investment committee of the Chicago Giving Circle, an organization focused on funding emerging not-for-profits in the Chicago area. Eric is a graduate of Yale University with a degree in Economics and Mathematics.